Use of the Afirma Xpression Atlas for cytologically indeterminate, Afirma Genomic Sequencing Classifier suspicious thyroid nodules: Clinicopathologic analysis with postoperative molecular testing

CONCLUSIONS: Afirma XA improved risk stratification of thyroid disease with a high risk of malignancy in Afirma GSC suspicious nodules. A negative Afirma XA result, however, should not be used as a rule-out test.PMID:38104250 | DOI:10.1093/ajcp/aqad169

Source: American Journal of Clinical Pathology - December 17, 2023 Category: Pathology Authors: Carlos A Munoz-Zuluaga Jonas J Heymann James P Solomon Ami Patel Momin T Siddiqui Theresa Scognamiglio Hamza N Gokozan Source Type: research